**Core Concept:** Nuchal translucency (NT) is a measurement taken during a fetal ultrasound examination, typically performed between 11 and 14 weeks of gestation. It is a measure of the distance between the skin and the hyperechoic layer underlying the skin in the fetal neck. Increased NT values are associated with an increased risk of chromosomal abnormalities, particularly trisomies 13, 18, and 21.

**Why the Correct Answer is Right:** Increased nuchal translucency is a marker for an increased risk of chromosomal abnormalities, particularly trisomies 13, 18, and 21, known as the common trisomies. These abnormalities can lead to severe developmental issues and disabilities in the affected fetus.

**Why Each Wrong Option is Incorrect:**

A. **Increased nuchal translucency is not characteristic of any specific genetic disorder or syndrome.** Each of the trisomies (13, 18, and 21) has distinct clinical features and outcomes, but increased NT is a marker for an increased risk of these abnormalities.

B. **The measurement of nuchal translucency is not limited to a specific gestational age.** While the measurement is typically performed between 11 and 14 weeks, it can be performed earlier or later in gestation depending on the obstetrician's preference and the patient's circumstances.

C. **Nuchal translucency is not solely determined by maternal age.** While maternal age is a risk factor for an increased NT, it is also influenced by other factors such as parental chromosomal abnormalities, maternal age, and other fetal factors.

D. **Increased nuchal translucency does not always indicate a chromosomal abnormality.** Although it is a marker for an increased risk, a normal NT measurement does not exclude the possibility of chromosomal abnormalities. Further diagnostic testing, such as chorionic villus sampling (CVS) or amniocentesis, should be considered in case of increased NT measurements.

**Clinical Pearl:** Nuchal translucency measurement is an important part of a routine prenatal ultrasound examination. A raised NT value should prompt further diagnostic testing, as it increases the likelihood of chromosomal abnormalities, particularly trisomies 13, 18, and 21. Maternal age is a significant risk factor, but other factors like parental chromosomal abnormalities and fetal factors also contribute to the measurement. Further testing should be considered to confirm the diagnosis and guide management decisions for the affected fetus and the expectant mother.